title: Role of nonnucleosides in the development of HAART-related lipid disturbances.
authors.forename: T
authors.initials: T
authors.lastname: García-Benayas
authors.forename: F
authors.initials: F
authors.lastname: Blanco
authors.forename: J J
authors.initials: JJ
authors.lastname: de la Cruz
authors.forename: M J
authors.initials: MJ
authors.lastname: Senchordi
authors.forename: J M
authors.initials: JM
authors.lastname: Gómez-Viera
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors